Gary S. Gillheeney, President and CEO at Organogenesis Holdings Inc. (ORGO), sold 629,674 shares at $6.06 ($3.8M) on 2022-05-13, disclosed to the SEC on 2022-05-17.
Open-market sale of $3.8M ORGO by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.06 | 14,810 | $90K | 2.4% |
| 2 | $6.06 | 14,810 | $90K | 2.4% |
| 3 | $6.18 | 121,580 | $751K | 19.8% |
| 4 | $6.18 | 121,580 | $751K | 19.8% |
| 5 | $5.92 | 80,369 | $476K | 12.5% |
| 6 | $5.92 | 80,369 |
| $476K |
| 12.5% |
| 7 | $5.90 | 98,078 | $579K | 15.3% |
| 8 | $5.90 | 98,078 | $579K | 15.3% |
| Total | $6.02 avg | 629,674 | $3.8M | 100% |
| Filing → |
| ORGO | SELL | 2024-12-09 | $423K | — | Filing → |
| ORGO | SELL | 2022-06-03 | $2.7M | — | Filing → |
| ORGO | SELL | 2022-05-31 | $2.6M | — | Filing → |